{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:18:31Z","timestamp":1788391111458,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["971324"],"award-info":[{"award-number":["971324"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s13346-024-01693-9","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T09:02:38Z","timestamp":1725094958000},"page":"770-785","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Simultaneous therapeutic and diagnostic applications of magnetic PLGA nanoparticles loaded with doxorubicin in rabbit"],"prefix":"10.1007","volume":"15","author":[{"given":"Zahra","family":"Salmasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faezeh","family":"Nazeran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frarhad","family":"Eisvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manouchehr","family":"Teymouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Khordad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2897-0039","authenticated-orcid":false,"given":"Jafar","family":"Mosafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,31]]},"reference":[{"key":"1693_CR1","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jconrel.2015.08.041","volume":"219","author":"D Liu","year":"2015","unstructured":"Liu D, Auguste DT. Cancer targeted therapeutics: from molecules to drug delivery vehicles. J Controlled Release. 2015;219:632\u201343.","journal-title":"J Controlled Release"},{"issue":"21","key":"1693_CR2","doi-asserted-by":"publisher","first-page":"2209529","DOI":"10.1002\/adma.202209529","volume":"35","author":"Z Li","year":"2023","unstructured":"Li Z, Zou J, Chen X. In response to precision medicine: current subcellular targeting strategies for cancer therapy. Adv Mater. 2023;35(21):2209529.","journal-title":"Adv Mater"},{"issue":"12","key":"1693_CR3","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nnano.2011.166","volume":"6","author":"H Cabral","year":"2011","unstructured":"Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M, et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol. 2011;6(12):815\u201323.","journal-title":"Nat Nanotechnol"},{"issue":"3","key":"1693_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.7150\/thno.5327","volume":"3","author":"JU Menon","year":"2013","unstructured":"Menon JU, Jadeja P, Tambe P, Vu K, Yuan B, Nguyen KT. Nanomaterials for photo-based diagnostic and therapeutic applications. Theranostics. 2013;3(3):152.","journal-title":"Theranostics"},{"issue":"9","key":"1693_CR5","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.3390\/ijms23095253","volume":"23","author":"A-G Niculescu","year":"2022","unstructured":"Niculescu A-G, Grumezescu AM. Novel tumor-targeting nanoparticles for cancer treatment\u2014A review. Int J Mol Sci. 2022;23(9):5253.","journal-title":"Int J Mol Sci"},{"key":"1693_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2147\/IJN.S40579","volume":"8","author":"H Sah","year":"2013","unstructured":"Sah H, Thoma LA, Desu HR, Sah E, Wood GC. Concepts and practices used to develop functional PLGA-based nanoparticulate systems. Int J Nanomed. 2013;8:747.","journal-title":"Int J Nanomed"},{"issue":"2","key":"1693_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Pr\u00e9at V. PLGA-based nanoparticles: an overview of biomedical applications. J Controlled Release. 2012;161(2):505\u201322.","journal-title":"J Controlled Release"},{"key":"1693_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-021-02179-4","volume":"23","author":"J Wang","year":"2022","unstructured":"Wang J, Gong J, Wei Z. Strategies for liposome drug delivery systems to improve tumor treatment efficacy. AAPS PharmSciTech. 2022;23:1\u201314.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"1693_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1515\/ntrev-2012-0084","volume":"2","author":"J Li","year":"2013","unstructured":"Li J, Sabliov C. PLA\/PLGA nanoparticles for delivery of drugs across the blood-brain barrier. Nanatechnol Reviews. 2013;2(3):241\u201357.","journal-title":"Nanatechnol Reviews"},{"issue":"5","key":"1693_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.nantod.2012.08.005","volume":"7","author":"C Deng","year":"2012","unstructured":"Deng C, Jiang Y, Cheng R, Meng F, Zhong Z. Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: promises, progress and prospects. Nano Today. 2012;7(5):467\u201380.","journal-title":"Nano Today"},{"issue":"1","key":"1693_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","volume":"75","author":"A Kumari","year":"2010","unstructured":"Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75(1):1\u201318.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"5","key":"1693_CR12","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/polym15051123","volume":"15","author":"M Elmowafy","year":"2023","unstructured":"Elmowafy M, Shalaby K, Elkomy MH, Alsaidan OA, Gomaa HA, Abdelgawad MA, et al. Polymeric nanoparticles for delivery of Natural Bioactive agents: recent advances and challenges. Polymers. 2023;15(5):1123.","journal-title":"Polymers"},{"issue":"4","key":"1693_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5(4):505\u201315.","journal-title":"Mol Pharm"},{"issue":"5","key":"1693_CR14","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1021\/nl900031y","volume":"9","author":"SD Perrault","year":"2009","unstructured":"Perrault SD, Walkey C, Jennings T, Fischer HC, Chan WC. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 2009;9(5):1909\u201315.","journal-title":"Nano Lett"},{"issue":"1","key":"1693_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0005-2736(92)90136-A","volume":"1104","author":"D Liu","year":"1992","unstructured":"Liu D, Mori A, Huang L. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM 1-containing liposomes. Biochim et Biophys Acta (BBA)-Biomembranes. 1992;1104(1):95\u2013101.","journal-title":"Biochim et Biophys Acta (BBA)-Biomembranes"},{"issue":"31","key":"1693_CR16","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.1016\/j.biomaterials.2011.07.004","volume":"32","author":"J Guo","year":"2011","unstructured":"Guo J, Gao X, Su L, Xia H, Gu G, Pang Z, et al. Aptamer-functionalized PEG\u2013PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials. 2011;32(31):8010\u201320.","journal-title":"Biomaterials"},{"key":"1693_CR17","doi-asserted-by":"publisher","first-page":"102915","DOI":"10.1016\/j.pdpdt.2022.102915","volume":"39","author":"VR Shinde","year":"2022","unstructured":"Shinde VR, Revi N, Murugappan S, Singh SP, Rengan AK. Enhanced permeability and retention effect: a key facilitator for solid tumor targeting by nanoparticles. Photodiagn Photodyn Ther. 2022;39:102915.","journal-title":"Photodiagn Photodyn Ther"},{"issue":"12","key":"1693_CR18","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/pharmaceutics14122728","volume":"14","author":"HO Alsaab","year":"2022","unstructured":"Alsaab HO, Alharbi FD, Alhibs AS, Alanazi NB, Alshehri BY, Saleh MA, et al. PLGA-Based nanomedicine: history of Advancement and Development in clinical applications of multiple diseases. Pharmaceutics. 2022;14(12):2728.","journal-title":"Pharmaceutics"},{"key":"1693_CR19","doi-asserted-by":"publisher","first-page":"114079","DOI":"10.1016\/j.addr.2021.114079","volume":"180","author":"D Shi","year":"2022","unstructured":"Shi D, Beasock D, Fessler A, Szebeni J, Ljubimova JY, Afonin KA, et al. To PEGylate or not to PEGylate: immunological properties of nanomedicine\u2019s most popular component, polyethylene glycol and its alternatives. Adv Drug Deliv Rev. 2022;180:114079.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"1693_CR20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ejpb.2007.02.016","volume":"66","author":"F Tewes","year":"2007","unstructured":"Tewes F, Munnier E, Antoon B, Okassa LN, Cohen-Jonathan S, Marchais H, et al. Comparative study of doxorubicin-loaded poly (lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm. 2007;66(3):488\u201392.","journal-title":"Eur J Pharm Biopharm"},{"issue":"25","key":"1693_CR21","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.2174\/092986709788803312","volume":"16","author":"C Carvalho","year":"2009","unstructured":"Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS, et al. Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem. 2009;16(25):3267\u201385.","journal-title":"Curr Med Chem"},{"key":"1693_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jconrel.2019.11.016","volume":"317","author":"M Gon\u00e7alves","year":"2020","unstructured":"Gon\u00e7alves M, Mignani S, Rodrigues J, Tom\u00e1s H. A glance over doxorubicin based-nanotherapeutics: from proof-of-concept studies to solutions in the market. J Controlled Release. 2020;317:347\u201374.","journal-title":"J Controlled Release"},{"key":"1693_CR23","first-page":"2661","volume":"7","author":"W-H Xu","year":"2012","unstructured":"Xu W-H, Han M, Dong Q, Fu Z-X, Diao Y-Y, Liu H, et al. Doxorubicin-mediated radiosensitivity in multicellular spheroids from a lung cancer cell line is enhanced by composite micelle encapsulation. Int J Nanomed. 2012;7:2661.","journal-title":"Int J Nanomed"},{"issue":"6","key":"1693_CR24","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.ejca.2014.01.012","volume":"50","author":"J-Y Blay","year":"2014","unstructured":"Blay J-Y, Leahy MG, Nguyen BB, Patel SR, Hohenberger P, Santoro A, et al. Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas. Eur J Cancer. 2014;50(6):1137\u201347.","journal-title":"Eur J Cancer"},{"issue":"21","key":"1693_CR25","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.1016\/j.biomaterials.2013.03.044","volume":"34","author":"Q Xu","year":"2013","unstructured":"Xu Q, Leong J, Chua QY, Chi YT, Chow PK-H, Pack DW, et al. Combined modality doxorubicin-based chemotherapy and chitosan-mediated p53 gene therapy using double-walled microspheres for treatment of human hepatocellular carcinoma. Biomaterials. 2013;34(21):5149\u201362.","journal-title":"Biomaterials"},{"issue":"12","key":"1693_CR26","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"W Hiddemann","year":"2005","unstructured":"Hiddemann W, Kneba M, Dreyling M, Schmitz N, Lengfelder E, Schmits R, et al. Frontline therapy with Rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German low-Grade Lymphoma Study Group. Blood. 2005;106(12):3725\u201332.","journal-title":"Blood"},{"key":"1693_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jconrel.2020.08.033","volume":"328","author":"M Mohammadi","year":"2020","unstructured":"Mohammadi M, Arabi L, Alibolandi M. Doxorubicin-loaded composite nanogels for cancer treatment. J Controlled Release. 2020;328:171\u201391.","journal-title":"J Controlled Release"},{"key":"1693_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejps.2015.08.011","volume":"80","author":"M Teymouri","year":"2015","unstructured":"Teymouri M, Farzaneh H, Badiee A, Golmohammadzadeh S, Sadri K, Jaafari MR. Investigation of Hexadecylphosphocholine (miltefosine) usage in pegylated liposomal doxorubicin as a synergistic ingredient: in vitro and in vivo evaluation in mice bearing C26 colon carcinoma and B16F0 melanoma. Eur J Pharm Sci. 2015;80:66\u201373.","journal-title":"Eur J Pharm Sci"},{"key":"1693_CR29","doi-asserted-by":"crossref","unstructured":"O\u2019Brien MER, Wigler N, Inbar M, et al. Reduced cardiac toxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin (Caelyx\/Doxil) vs. doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol. 2004;15:440\u2013449.","DOI":"10.1093\/annonc\/mdh097"},{"issue":"2","key":"1693_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/antiox7020031","volume":"7","author":"P Brenneisen","year":"2018","unstructured":"Brenneisen P, Reichert AS. Nanotherapy and reactive oxygen species (ROS) in cancer: a novel perspective. Antioxidants. 2018;7(2):31.","journal-title":"Antioxidants"},{"key":"1693_CR31","doi-asserted-by":"crossref","unstructured":"Mao JN, Li AJ, Zhao LP, Gao L, Xu WT, Hong XS, et al. editors. PEG-PLGA nanoparticles entrapping doxorubicin reduced doxorubicin-induced cardiotoxicity in rats. Advanced Materials Research; 2014: Trans Tech Publ.","DOI":"10.4028\/www.scientific.net\/AMR.912-914.263"},{"issue":"2","key":"1693_CR32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ejpb.2014.06.020","volume":"88","author":"C Chittasupho","year":"2014","unstructured":"Chittasupho C, Lirdprapamongkol K, Kewsuwan P, Sarisuta N. Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles. Eur J Pharm Biopharm. 2014;88(2):529\u201338.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"1693_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/adt.2022.102","volume":"21","author":"P Sandal","year":"2023","unstructured":"Sandal P, Kumari L, Patel P, Singh A, Singh D, Gupta GD, et al. Doxorubicin conjugates: an efficient Approach for enhanced therapeutic efficacy with reduced side effects. Assay Drug Dev Technol. 2023;21(4):137\u201356.","journal-title":"Assay Drug Dev Technol"},{"issue":"2","key":"1693_CR34","doi-asserted-by":"publisher","first-page":"023501","DOI":"10.1088\/1468-6996\/16\/2\/023501","volume":"16","author":"W Wu","year":"2015","unstructured":"Wu W, Wu Z, Yu T, Jiang C, Kim W-S. Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications. Sci Technol Adv Mater. 2015;16(2):023501.","journal-title":"Sci Technol Adv Mater"},{"issue":"5","key":"1693_CR35","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1007\/s11095-012-0679-7","volume":"29","author":"MV Yigit","year":"2012","unstructured":"Yigit MV, Moore A, Medarova Z. Magnetic nanoparticles for cancer diagnosis and therapy. Pharm Res. 2012;29(5):1180\u20138.","journal-title":"Pharm Res"},{"issue":"6","key":"1693_CR36","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3390\/pharmaceutics15061714","volume":"15","author":"J-K Hsiao","year":"2023","unstructured":"Hsiao J-K, Chen C-L, Hsieh W-Y, Kuo K-L. Theranostic role of iron oxide nanoparticle for treating renal anemia: evidence of efficacy and significance by MRI, histology and biomarkers. Pharmaceutics. 2023;15(6):1714.","journal-title":"Pharmaceutics"},{"issue":"3","key":"1693_CR37","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1021\/mp0500014","volume":"2","author":"TK Jain","year":"2005","unstructured":"Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V. iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm. 2005;2(3):194\u2013205.","journal-title":"Mol Pharm"},{"issue":"4","key":"1693_CR38","first-page":"389","volume":"37","author":"CC Hua","year":"2008","unstructured":"Hua CC, Zakaria S, Farahiyan R, Khong LT. Size-controlled synthesis and characterization of Fe. Sains Malaysiana. 2008;37(4):389\u201394.","journal-title":"Sains Malaysiana"},{"issue":"2","key":"1693_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/japtr.japtr_246_21","volume":"13","author":"AD Wulandari","year":"2022","unstructured":"Wulandari AD, Sutriyo S, Rahmasari R. Synthesis conditions and characterization of superparamagnetic iron oxide nanoparticles with oleic acid stabilizer. J Adv Pharm Tech Res. 2022;13(2):89.","journal-title":"J Adv Pharm Tech Res"},{"issue":"5","key":"1693_CR40","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/pi.4154","volume":"61","author":"M Ashjari","year":"2012","unstructured":"Ashjari M, Khoee S, Mahdavian AR. A multiple emulsion method for loading 5-fluorouracil into a magnetite\u2010loaded nanocapsule: a physicochemical investigation. Polym Int. 2012;61(5):850\u20139.","journal-title":"Polym Int"},{"issue":"3","key":"1693_CR41","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3390\/nano12030576","volume":"12","author":"T Pulingam","year":"2022","unstructured":"Pulingam T, Foroozandeh P, Chuah J-A, Sudesh K. Exploring various techniques for the chemical and biological synthesis of polymeric nanoparticles. Nanomaterials. 2022;12(3):576.","journal-title":"Nanomaterials"},{"key":"1693_CR42","doi-asserted-by":"publisher","first-page":"108485","DOI":"10.1016\/j.abb.2020.108485","volume":"691","author":"M Hashemi","year":"2020","unstructured":"Hashemi M, Shamshiri A, Saeedi M, Tayebi L, Yazdian-Robati R. Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs. Arch Biochem Biophys. 2020;691:108485.","journal-title":"Arch Biochem Biophys"},{"key":"1693_CR43","doi-asserted-by":"crossref","unstructured":"Mosafer J, Abnous K, Tafaghodi M, Jafarzadeh H, Ramezani M. Preparation and characterization of uniform-sized PLGA nanospheres encapsulated with oleic acid-coated magnetic-Fe3O4 nanoparticles for simultaneous diagnostic and therapeutic applications. Colloids Surf Physicochem Eng Aspects. 2016.","DOI":"10.1016\/j.colsurfa.2016.11.056"},{"key":"1693_CR44","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejpb.2016.12.009","volume":"113","author":"J Mosafer","year":"2017","unstructured":"Mosafer J, Abnous K, Tafaghodi M, Mokhtarzadeh A, Ramezani M. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy. Eur J Pharm Biopharm. 2017;113:60\u201374.","journal-title":"Eur J Pharm Biopharm"},{"key":"1693_CR45","doi-asserted-by":"crossref","unstructured":"Mosafer J, Abnous K, Tafaghodi M, Jafarzadeh H, Ramezani M. Preparation and characterization of uniform-sized PLGA nanospheres encapsulated with oleic acid-coated magnetic-Fe3O4 nanoparticles for simultaneous diagnostic and therapeutic applications. Colloids Surf Physicochem Eng Aspects. 2017;514:146\u201354.","DOI":"10.1016\/j.colsurfa.2016.11.056"},{"key":"1693_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.msec.2016.11.053","volume":"72","author":"J Mosafer","year":"2017","unstructured":"Mosafer J, Teymouri M, Abnous K, Tafaghodi M, Ramezani M. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells. Mater Sci Eng C. 2017;72:123\u201333.","journal-title":"Mater Sci Eng C"},{"key":"1693_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.msec.2016.11.053","volume":"72","author":"J Mosafer","year":"2017","unstructured":"Mosafer J, Teymouri M, Abnous K, Tafaghodi M, Ramezani M. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells. Mater Sci Engineering: C. 2017;72:123\u201333.","journal-title":"Mater Sci Engineering: C"},{"issue":"1","key":"1693_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1267\/ahc.20-00032","volume":"54","author":"K Cizkova","year":"2021","unstructured":"Cizkova K, Foltynkova T, Gachechiladze M, Tauber Z. Comparative analysis of immunohistochemical staining intensity determined by light microscopy, ImageJ and QuPath in placental Hofbauer cells. Acta Histochem Cytochem. 2021;54(1):21\u20139.","journal-title":"Acta Histochem Cytochem"},{"issue":"5","key":"1693_CR49","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/bjd.12186","volume":"168","author":"H Kwon","year":"2013","unstructured":"Kwon H, Lee J, Yoon J, Park S, Ryu H, Park B, et al. The clinical and histological effect of home-use, combination blue\u2013red LED phototherapy for mild\u2010to\u2010moderate acne vulgaris in Korean patients: a double\u2010blind, randomized controlled trial. Br J Dermatol. 2013;168(5):1088\u201394.","journal-title":"Br J Dermatol"},{"issue":"8","key":"1693_CR50","doi-asserted-by":"publisher","first-page":"15767","DOI":"10.3390\/ijms140815767","volume":"14","author":"G Musumeci","year":"2013","unstructured":"Musumeci G, Castrogiovanni P, Loreto C, Castorina S, Pichler K, Weinberg AM. Post-traumatic caspase-3 expression in the adjacent areas of growth plate injury site: a morphological study. Int J Mol Sci. 2013;14(8):15767\u201384.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1693_CR51","doi-asserted-by":"publisher","first-page":"13065","DOI":"10.1038\/s41598-021-92391-w","volume":"11","author":"R Nosrati","year":"2021","unstructured":"Nosrati R, Abnous K, Alibolandi M, Mosafer J, Dehghani S, Taghdisi SM, et al. Targeted SPION siderophore conjugate loaded with doxorubicin as a theranostic agent for imaging and treatment of colon carcinoma. Sci Rep. 2021;11(1):13065.","journal-title":"Sci Rep"},{"issue":"1","key":"1693_CR52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0378-5173(93)90015-8","volume":"94","author":"B Magenheim","year":"1993","unstructured":"Magenheim B, Levy M, Benita S. A new in vitro technique for the evaluation of drug release profile from colloidal carriers-ultrafiltration technique at low pressure. Int J Pharm. 1993;94(1):115\u201323.","journal-title":"Int J Pharm"},{"key":"1693_CR53","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jconrel.2015.04.026","volume":"209","author":"M Alibolandi","year":"2015","unstructured":"Alibolandi M, Ramezani M, Abnous K, Sadeghi F, Atyabi F, Asouri M, et al. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer. J Controlled Release. 2015;209:88\u2013100.","journal-title":"J Controlled Release"},{"key":"1693_CR54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.drup.2016.10.003","volume":"29","author":"AA Gabizon","year":"2016","unstructured":"Gabizon AA, Patil Y, La-Beck NM. New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy. Drug Resist Updates. 2016;29:90\u2013106.","journal-title":"Drug Resist Updates"}],"updated-by":[{"DOI":"10.1007\/s13346-024-01725-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000}}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01693-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01693-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01693-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T19:05:46Z","timestamp":1735499146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01693-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1693"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01693-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4373471\/v1","asserted-by":"object"}]},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,31]]},"assertion":[{"value":"29 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13346-024-01725-4","URL":"https:\/\/doi.org\/10.1007\/s13346-024-01725-4","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures and protocols were in accordance of the instructions of the Ethics Committee of Mashhad University of Medical Sciences. The ethical number was (IR.MUMS.PHARMACY.REC.1398.009).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All involved persons (subjects or legally authorized representative) gave their informed consent (written or verbal, as appropriate) prior to study inclusion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}